Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FXQ5A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,299
Award facts
- Contract value 100% obligated
- $16,299.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,299.04 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML AutoInjector on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis and rheumatoid arthritis, and the auto-injector formulation enables self-administration by military and veteran healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As the largest pharmaceutical distributor in the United States, AmerisourceBergen leverages this strategic contract vehicle to deliver critical medical commodities across multiple therapeutic domains to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXQ5A?
SPE2DR26FXQ5A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FXQ5A worth?
The government has obligated $16,299 on SPE2DR26FXQ5A.
Is contract SPE2DR26FXQ5A an order under another contract?
Yes. SPE2DR26FXQ5A is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ5A competed?
The extent of competition for SPE2DR26FXQ5A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award